Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-18

FDA Approved: AMPHETAMINE SULFATE — Supplemental Application (Solco Healthcare US, LLC)

View source ↗

Summary

FDA approved a supplemental application for Amphetamine Sulfate from Solco Healthcare US, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amphetamine sulfate (amphetamine sulfate)

Snippet

SUPPL AP for AMPHETAMINE SULFATE (AMPHETAMINE SULFATE)